GE HealthCare Technologies Inc. (GEHC)vsCatheter Precision Inc. (VTAK)
GEHC
GE HealthCare Technologies Inc.
$72.20
+1.75%
HEALTHCARE · Cap: $32.38B
VTAK
Catheter Precision Inc.
$1.20
+0.84%
HEALTHCARE · Cap: $3.05M
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 3437400% more annual revenue ($20.63B vs $600,000). GEHC leads profitability with a 10.1% profit margin vs 0.0%. VTAK trades at a lower P/E of 0.1x. GEHC earns a higher WallStSmart Score of 60/100 (C+).
GEHC
Buy60
out of 100
Grade: C+
VTAK
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$72.20
$41.26 premium
Margin of Safety
+99.2%
Fair Value
$228.68
Current Price
$1.20
$227.48 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Attractively priced relative to earnings
Reasonable price relative to book value
Revenue surging 128.0% year-over-year
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -1.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bull Case : VTAK
The strongest argument for VTAK centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 128.0% demonstrates continued momentum.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Bear Case : VTAK
The primary concerns for VTAK are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
GEHC profiles as a value stock while VTAK is a hypergrowth play — different risk/reward profiles.
GEHC carries more volatility with a beta of 1.18 — expect wider price swings.
VTAK is growing revenue faster at 128.0% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (60/100 vs 38/100). VTAK offers better value entry with a 99.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Catheter Precision Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company is headquartered in Fort Mill, South Carolina.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?